MRC1 and neoplasm: These cells displayed decreased stemness both in vitro and in vivo, suggesting that double-positive GC is not observed in clinical settings due to the novel introduction of a DNA MMR gene deficiency negatively affecting tumour stemness when EBV positivity is already present.